Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies

Lignende værker

• Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia
  af: Viktrup, Lars, et al.
  Udgivet: (2012)
• Validity of the “Bother Score” in the Evaluation and Treatment of Symptomatic Benign Prostatic Hyperplasia
  af: O’Leary, Michael P
  Udgivet: (2005)
• Tadalafil for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a review of clinical data in Asian men and an update on the mechanism of action
  af: Yokoyama, Osamu, et al.
  Udgivet: (2015)
• The Efficacy and Safety of Tadalafil 5 mg Once Daily in Korean Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: An Integrated Analysis
  af: Lee, Sung Won, et al.
  Udgivet: (2014)
• A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction
  af: Hatzimouratidis, Konstantinos
  Udgivet: (2014)